Brain & NeurologyLLLT demonstrated an early between-group advantage over MT at 4 weeks in pain reduction and sensorimotor recovery in post-stroke CRPS-I. However, in the long run, no overall between-group superiority was noted, as both groups achieved comparable outcomes.
Trial · October 1, 2026 · De SK et al.
Brain & NeurologyMonotherapies provided moderate yet meaningful protection.
Study · September 7, 2026 · Kayani H et al.
Brain & NeurologyPharmacological p53 inhibition with PFT-α or UFL1 knockdown in donor EVs substantially diminished these therapeutic effects in vivo, confirming the central role of the UFL1/p53 axis.
Study · August 18, 2026 · Fang Y et al.
Brain & NeurologyNeuromodulation holds promise as a mechanistically informed and multi-target neuroprotective strategy for CCH-related cognitive impairment.
Review · August 1, 2026 · Qiao C et al.
Brain & NeurologyTranscriptome analysis further indicated that tPBM may preserves synaptic plasticity homeostasis by modulating the PI3K-Akt, cAMP-PKA, and calcium signaling pathways, with Adora2a identified as a potential therapeutic target.
Study · July 9, 2026 · Cao Q et al.
Brain & NeurologyThese findings reveal complementary pathways for tPBM in AD intervention, highlighting that CW and 40-Hz light offer modality-specific therapeutic advantages: The former targets cerebrovascular dysfunction, while the latter addresses Aβ plaque deposition.
Study · June 23, 2026 · Zhang B et al.
Brain & NeurologyGiven that daytime functioning is of high clinical relevance for patients with insomnia disorder, daytime sleepiness should be further evaluated as treatment target and may be addressed with light therapy.
Trial · June 4, 2026 · Schmid SR et al.
Brain & NeurologyEarly LLLT is associated with sustained functional recovery after neonatal hypoxic–ischemic injury. These effects may involve early modulation of antioxidant and pro-survival signaling pathways, although the mechanisms underlying long-term outcomes require further investigation.
Study · April 28, 2026 · Liu P et al.
Brain & NeurologyPBM modulated oxidative stress, hypoxia signalling and thrombo-inflammatory pathways across endothelial cells, astrocytes and pericytes.
Study · April 11, 2026 · Domocos M et al.
Brain & NeurologyAcute transcranial PBM did not influence cycling performance or perceptual and physiological responses in trained athletes. These findings suggest that the applied PBM parameters may have been insufficient to elicit measurable cortical or performance effects.
Study · March 16, 2026 · Arrighi T et al.
Brain & NeurologyThe evidence supporting tPBM for spasticity in pediatric CP is in a pre-preliminary stage, defined by a critically small number of studies, a pervasive lack of methodological rigor, and an absence of pediatric-specific safety protocols.
Review · February 28, 2026 · Jiménez A et al.
Brain & NeurologyWe explored the feasibility of applying graph-theoretical network analysis to fNIRS data for the early identification of non-responders to tPBM treatment before its completion.
Study · February 12, 2026 · Chun M et al.
Brain & NeurologyThis work presents a promising, noninvasive, and multitargeted strategy for PD treatment, with potential implications for translational research.
Study · January 26, 2026 · Su TY et al.
Brain & NeurologyKEY POINTS: Transcranial photobiomodulation (tPBM) with a 1064 nm laser can alleviate pain.
Study · January 5, 2026 · Wang Z et al.
Brain & NeurologyThese findings provide additional evidence that humans show seasonality and that, for mood, it involves parts of the amygdala.
Study · December 22, 2025 · Campbell I et al.
Brain & NeurologyPreclinical and clinical evidence demonstrate tPBM's potential to mitigate neuronal damage and promote recovery across acute, subacute, and chronic phases of IS.
Review · November 27, 2025 · Tang L et al.
Brain & NeurologyThe safety of the device and its sterilization conditions were demonstrated as there was no cell death or contamination during in vitro stimulation.
Study · November 12, 2025 · Oliveira S et al.
Brain & NeurologyWe highlight the need for large-scale, placebo-controlled studies for both conditions.
Review · October 17, 2025 · Barone-Rochette G et al.